Clinical Trial Update: DIROXIMEL FUMARATE TO REDUCE PERIHAEMATOMAL OEDEMA IN INTRACEREBRAL HAEMORRHAGE: DOUBLE BLIND RANDOMIZED CLINICAL TRIAL [Phase 2]

View source ↗

Summary

A Phase 2 double-blind randomized trial is evaluating diroximel fumarate for reducing perihematomal edema in intracerebral hemorrhage (stroke) and is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage
• Stroke

Drugs mentioned

• Diroximel Fumarate (diroximel fumarate)

Snippet

Sponsor: University Hospital, Lille | Conditions: Stroke | Phase 2 | Status: RECRUITING